Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Annalise Hilts
Observed names:
A Hilts,
A. Hilts
Observed institution:
Analysis Group (United States)
OpenAlex ID:
A5004877883
Real-World Persistence to Biologic Therapies and Its Impact on Outcomes in Patients With Asthma
2025
·
J. Kwiatek
, A. Deb
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
3
Real-world perioperative treatment patterns and economic burden of recurrence in early-stage HER2-negative breast cancer: a SEER-Medicare study
2024
·
Jagadeswara Rao Earla
, Kalé Kponee-Shovein
, et al.
·
Journal of Medical Economics
·
3
Real-world perioperative treatment patterns and burden of recurrent disease in patients with high-risk endometrial cancer: a SEER-Medicare study
2024
·
Vimalanand S. Prabhu
, Kalé Kponee-Shovein
, et al.
·
Journal of Medical Economics
·
3
EE458 Economic Burden of Disease Recurrence in Elderly Patients With Human Epidermal Growth Factor Receptor 2-Negative (HER2–) Early Breast Cancer (eBC)
2024
·
JR Earla
, AW Kurian
, et al.
·
Value in Health
·
2
PDF
Real-world impact of mepolizumab on pediatric and adolescent patients with severe asthma
2025
·
Michelle L. Hernandez
, Tom Corbridge
, et al.
·
Journal of Allergy and Clinical Immunology Global
·
1
Mepolizumab Reduces Systemic Corticosteroid (SCS)-Related Toxicities Compared to Chronic SCS Use in Patients with EGPA
2025
·
Thanai Pongdee
, Arijita Deb
, et al.
·
Journal of Allergy and Clinical Immunology
·
1
PDF
Comparative Effectiveness of Lenalidomide/Dexamethasone-Based Triplet Regimens for Treatment of Relapsed and/or Refractory Multiple Myeloma in Subgroups Defined By Cytogenetic Risk
2022
·
Larysa Sanchez
, Mu Cheng
, et al.
·
Blood
·
1
Clinical Outcomes Differ by Adherence to Biologic Therapies in Patients with Asthma and Chronic Rhinosinusitis with Nasal Polyps
2026
·
Rohit Katial
, Justin Kwiatek
, et al.
·
Journal of Allergy and Clinical Immunology
Correction: Clinical Burden of Recurrent Disease in High-Risk Endometrial Cancer
2025
·
Kalé Kponee-Shovein
, Vimalanand S. Prabhu
, et al.
·
Oncology and Therapy
PDF
Mepolizumab for the management of chronic rhinosinusitis with nasal polyps across the United States: A retrospective study
2025
·
Juan Carlos Cardet
, Jared Silver
, et al.
·
Journal of Allergy and Clinical Immunology Global
Clinical Burden of Recurrent Disease in High-Risk Endometrial Cancer
2025
·
Kalé Kponee-Shovein
, Vimalanand S. Prabhu
, et al.
·
Oncology and Therapy
PDF
EE255 Economic Impact of Recurrence in High-Risk Early-Stage Estrogen-Receptor Positive (ER+)/Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Breast Cancer (BC)
2025
·
Jagadeswara Rao Earla
, Amin Haiderali
, et al.
·
Value in Health
Correlation Between Disease-Free Survival Endpoints and Overall Survival in Elderly Patients with Early-Stage HER2-Negative Breast Cancer: A SEER-Medicare Analysis
2024
·
Jagadeswara R. Earla
, Allison W. Kurian
, et al.
·
Advances in Therapy
PDF
Real-world Mepolizumab Use for Chronic Rhinosinusitis With Nasal Polyps and Severe Asthma Improves Clinical/economic Outcomes
2024
·
J. Cardet
, M. Maldonado-Puebla
, et al.
·
Annals of Allergy Asthma & Immunology
PDF
Disease-free survival as a predictor of overall survival in patients with high-risk endometrial cancer receiving adjuvant therapy
2024
·
Linda Duska
, Vimalanand Prabhu
, et al.
·
Gynecologic Oncology
EE301 Economic Burden of Disease Recurrence in Elderly Patients With High-Risk Endometrial Cancer (HR-EC) Receiving Adjuvant Therapy (AT)
2024
·
V Prabhu
, K. Kponee-Shovein
, et al.
·
Value in Health
153P Correlation between disease free survival (DFS) endpoints and overall survival (OS) in elderly patients with human epidermal growth factor receptor 2-negative (HER2–) early breast cancer (eBC)
2024
·
M.E. Robson
, J.R. Earla
, et al.
·
ESMO Open
PDF
Real-World Impact of Mepolizumab on Pediatric and Adolescent Patients With Severe Asthma in the United States
2024
·
T. Corbridge
, M. Mahendran
, et al.
Abstract B017: Disease free survival as a predictor of overall survival in patients with high-risk endometrial cancer receiving adjuvant chemotherapy
2024
·
Kalé Kponee-Shovein
, Vimalanand S. Prabhu
, et al.
·
Clinical Cancer Research
54 Real-world perioperative treatment patterns and overall survival among patients with high-risk endometrial cancer
2024
·
Kalé Kponee-Shovein
, Vimalanand S. Prabhu
, et al.
·
International Journal of Gynecological Cancer
Effectiveness of Switching to Mepolizumab from Other Biologics in Asthma Patients: A Real-World Analysis
2024
·
Thomas Corbridge
, Alexandra Stach-Klysh
, et al.
·
Journal of Allergy and Clinical Immunology
Real-World Effectiveness of Mepolizumab in Patients With Chronic Rhinosinusitis With Nasal Polyps: A Pre/Post Assessment of Oral Corticosteroid Use and Sinus Surgery in the US
2024
·
Martin Maldonado-Puebla
, Juan Carlos Cardet
, et al.
·
Journal of Allergy and Clinical Immunology
Impact réel du switch d’autres biologiques vers mépolizumab chez les patients asthmatiques sévères
2024
·
A. Deb
, C. Gao
, et al.
·
Revue des Maladies Respiratoires Actualités
Real-world Impact of Switching to Mepolizumab From Other Biologics in Patients With Asthma
2023
·
A. Deb
, C. Gao
, et al.
Show more works
View as search
Works count:
24
Citation count:
14
H-index:
3
I10-index:
Year
Topic
Type
